LYTIR

Company · PMN

ProMIS Neurosciences Inc.

Nasdaq's symbol directory lists PMN on Nasdaq as “ProMIS Neurosciences Inc. - Common Shares”.

In the 12 months to Nov 19, 2026: insiders bought on 4 occasions ($165K); 4 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $165K in total; Insider sales: $0 in total.Aug: Insider purchases $30KOct: Insider purchases $5KNov: Insider purchases $129KDecJanFebMarAprMayJunJulAugSepOctNov$129K
Insider purchases above the line: $165KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Eugene Williams bought on 2 days latest Nov 4, 2026 bought $96K
  2. Neil Cashman, Chief Scientific Officer bought on 1 day latest Nov 2, 2026 bought $39K
  3. Johanne Kaplan, Chief Development Officer bought on 1 day latest Aug 5, 2026 bought $30K
Every trade (4)
  1. BUYEugene Williams bought Nov 4, 2026 26,500 shares filing $91K
  2. BUYNeil Cashman, Chief Scientific Officer bought Nov 2, 2026 10,000 shares filing $39K
  3. BUYEugene Williams bought Oct 30, 2026 1,316 shares filing $5K
  4. BUYJohanne Kaplan, Chief Development Officer bought Aug 5, 2026 2,280 shares filing $30K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Adage Capital Management, L.P. filed Nov 12, 2026 Schedule 13G passive filing 7.73%
  2. Great Point Partners, LLC filed Aug 14, 2026 Schedule 13G/A passive 736,881 shares filing 7.66%
  3. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. filed Aug 13, 2026 Schedule 13G/A passive 696,378 shares filing 7.8%
  4. Wellington Management Group LLP filed Aug 13, 2026 Schedule 13G/A passive filing 7.8%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 12, 2026
  2. Regulation FD disclosure filing Nov 12, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.